teleo-codex/inbox/queue/2026-04-29-cms-mssp-py2024-2-4b-savings-vbc-structural-proof.md
Teleo Agents 8c16c35fc7 vida: research session 2026-04-29 — 10 sources archived
Pentagon-Agent: Vida <HEADLESS>
2026-04-29 04:31:07 +00:00

4.6 KiB

type title author url date domain secondary_domains format status priority tags intake_tier
source CMS Medicare Shared Savings Program: 2024 Performance Year Financial and Quality Results — Record $2.48B Net Savings Centers for Medicare & Medicaid Services https://accountableforhealth.org/accountability-delivered-in-medicare-shared-savings-program-results-from-2024/ 2025-09-09 health
report unprocessed high
value-based-care
ACO
MSSP
CMS
payment-reform
structural-fix
belief-3
research-task

Content

CMS released performance year 2024 results for the Medicare Shared Savings Program (MSSP). Key findings:

Financial performance:

  • Net Medicare savings: $2.48 billion — record, 8th consecutive year of net savings
  • Gross savings (before shared savings payments): $6.6 billion total
  • 75% of ACOs earned shared savings, receiving $4.1 billion in performance payments
  • Per capita net savings: $241 (up $34 from 2023)
  • Per capita gross savings: $643 (up $128 from 2023)

Risk track distribution:

  • Two-thirds of ACOs participating in Level E or Enhanced (downside risk) tracks
  • ACOs in Level E and Enhanced generated more than two-thirds of all savings ($5.4B of $6.6B gross)

Quality metrics:

  • Nearly every ACO met CMS quality standards — continuing a decade-long trend
  • ACOs outperformed non-ACO physician groups on:
    • Screening for Depression and Follow-up Plan: 53.53% (ACO) vs 44.42% (non-ACO)
    • Controlling High Blood Pressure: 71.21% vs 67.82%
  • Improved performance on A1c control, cancer screening

Enrollment context:

  • Total MSSP ACO enrollment growing year-over-year
  • CMS 2026 rule making two-sided risk the default: new Ambulatory Specialty Model (ASM) for heart failure and low back pain, restricting one-sided MSSP participation

Agent Notes

Why this matters: This is the empirical proof that value-based care's structural fix thesis (Belief 3) actually works at scale. $2.48B in net annual savings is not aspirational — it's measured, audited, and eighth-year consecutive. This is the strongest single piece of evidence in the KB that VBC is more than policy proposal.

What surprised me: The quality improvement alongside cost reduction. The classic critique of VBC is that it will cut costs by under-treating patients. The ACO data shows the opposite — ACOs outperform peers on depression screening, BP control, cancer screening WHILE generating $2.48B in savings. Cost and quality are moving together.

What I expected but didn't find: Any evidence of MSSP performance deteriorating. Given the MA disruptions (CMS tightening, UHG losses, Humana exits), I expected MSSP to show similar stress. Instead it's accelerating.

KB connections:

Extraction hints:

  • PRIMARY: "MSSP ACOs generated record $2.48B in net Medicare savings in 2024 for the eighth consecutive year, while maintaining superior quality performance compared to non-ACO peers — empirically confirming that cost and quality improvement are achievable simultaneously under value-based payment"
  • SECONDARY: Two-thirds of MSSP ACOs now in downside risk tracks — the transition IS advancing despite slow aggregate payment statistics
  • The per capita savings growth ($34 more in net, $128 more in gross vs. 2023) shows acceleration, not stagnation

Context: Released September 2025. Most recent publicly available MSSP performance data. CMS simultaneously issued 2026 rules expanding mandatory risk-bearing — the structural direction is accelerating.

Curator Notes

PRIMARY CONNECTION: value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk WHY ARCHIVED: Belief 3 disconfirmation target — does VBC structural fix actually work? This is the strongest empirical answer: record $2.48B savings, 8th consecutive year, quality improving alongside costs. Disconfirmation FAILS — Belief 3 confirmed. EXTRACTION HINT: Focus on the cost-quality co-improvement (defeats the under-treatment critique) and the acceleration of downside risk adoption (2/3 of ACOs now in downside risk). Two claims, not one.